Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CLDI will rise by +35.07% over the next 2 Weeks and hit $0.79 by Wednesday, August 13, 2025. In that time frame, CLDI's share price is expected to range between $0.61 and $0.97.
BearishAverageBullishCLDI shares fell -7.38% in Wednesday, July 30, 2025's trading session, dropping from a previous close of $0.63 to move at $0.59. The stock demonstrated notable intraday movement (see CLDI's key stats for a full breakdown), fluctuating between $0.56 and $0.63, a +11.70% trading range. While recent weeks have seen some volatility, CLDI has managed to secure a -5.00% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 5.1M shares changing hands, 172.61M fewer than the previous session. This amounted to $2.98M in total market activity.
Will CLDI Continue Its Upward Trend?
According to analyst ratings and projections for CLDI, Calidi Biotherapeutics, Inc. shares are anticipated to increase by +39.55%, potentially reaching $0.97 per share by August 13, 2025. Short-term technical indicators currently suggest a bullish sentiment for CLDI. However, the stock has recorded 18 negative trading days within the past 30 sessions. Based on the CLDI stock forecast, now is a good time to buy CLDI stock because its current trading price is -25.96% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CLDI covering social and institutional perspectives.
CLDI Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CLDI's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 48.44% to 52.57%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 49.56%, suggests a neutral medium-term outlook. However, the 100-day RSI, at 43.10%, maintains a neutral outlook for the long term. Insights into CLDI's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Calidi Biotherapeutics Short-Term Forecasts
CLDI Forecast For Next 5 Days
Our algorithm anticipates Calidi Biotherapeutics (CLDI) stock could hit $0.69 by Aug 07, 2025. This represents a +18.53% fall from today's price, following a -20.85% change over the past five days.
CLDI Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Calidi Biotherapeutics, Inc. (CLDI) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $0.80, which would mean a +36.73% increase from the current price of $0.59. Projections for this period range from a high of $1.20 to a low of $0.41.
CLDI Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Calidi Biotherapeutics's price over the next three months point to a drop. CLDI stock is expected to peak at $1.34 on Sep 03, 2025 before potentially dipping to - on Oct 31, 2025. On average, CLDI is likely to trade around $0.02 in the coming 90 days.
Calidi Biotherapeutics Stock Forecast 2025
Based on our predictive models, Calidi Biotherapeutics (CLDI) is expected to trade between - and $1.34 throughout 2025. This would result in an average price of $0.01, potentially offering investors a -98.29% return from current levels.
Calidi Biotherapeutics, Inc. Monthly Forecast 2025–2026
July 2025
According to our latest forecast models, Calidi Biotherapeutics, Inc. (CLDI) is positioned to show a strong performance in July 2025. The price is predicted to move between $0.00 and $1.11, settling at an average of $0.03. This could translate to a -94.87% loss.
August 2025
Based on current market signals, Calidi Biotherapeutics, Inc. is projected to trend august 2025. We forecast a trading range from $0.00 to $1.17, with a likely average price of $0.03. Investors could expect a potential return of -94.87%.
September 2025
Our predictive algorithms indicate Calidi Biotherapeutics, Inc. stock may see a shift in September 2025. The expected range spans $0.00–$1.34, with an average target of $0.02. This represents a cautious outlook and a possible loss of -96.58%.
October 2025
Analyzing established trends, Calidi Biotherapeutics, Inc. looks set to move in October 2025. Projections place the stock between $0.00 and $1.20, averaging around $0.01. This suggests a -98.29% loss from current levels.
November 2025
Market indicators suggest Calidi Biotherapeutics, Inc. could experience notable changes during November 2025. Prices could fluctuate within $0.00 to $1.31, with a midpoint forecast of $0.01. The stock might deliver a -98.29% loss.
December 2025
Forecasting for December 2025, models estimate that Calidi Biotherapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.23, averaging $0.01. This signals a cautious trajectory with potential returns around -98.29%.
January 2026
According to our latest forecast models, Calidi Biotherapeutics, Inc. (CLDI) is positioned to show a strong performance in January 2026. The price is predicted to move between $0.00 and $1.23, settling at an average of $0.00. This could translate to a -100.00% loss.
February 2026
Based on current market signals, Calidi Biotherapeutics, Inc. is projected to trend february 2026. We forecast a trading range from $0.00 to $1.20, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
March 2026
Our predictive algorithms indicate Calidi Biotherapeutics, Inc. stock may see a shift in March 2026. The expected range spans $0.00–$1.27, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
April 2026
Analyzing established trends, Calidi Biotherapeutics, Inc. looks set to move in April 2026. Projections place the stock between $0.00 and $1.17, averaging around $0.00. This suggests a -100.00% loss from current levels.
May 2026
Market indicators suggest Calidi Biotherapeutics, Inc. could experience notable changes during May 2026. Prices could fluctuate within $0.00 to $1.17, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
June 2026
Forecasting for June 2026, models estimate that Calidi Biotherapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.21, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
July 2026
According to our latest forecast models, Calidi Biotherapeutics, Inc. (CLDI) is positioned to show a strong performance in July 2026. The price is predicted to move between $0.00 and $1.27, settling at an average of $0.00. This could translate to a -100.00% loss.
CLDI's history of dividends and stock splits also plays a role in long-term investor confidence.